APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,906,260 | +182.8% | 50,112 | +577.4% | 0.02% | +137.5% |
| Q2 2023 | $673,958 | -57.0% | 7,398 | -78.7% | 0.01% | -80.5% |
| Q2 2022 | $1,569,000 | -36.8% | 34,707 | -28.9% | 0.04% | -29.3% |
| Q1 2022 | $2,482,000 | -50.0% | 48,840 | -67.6% | 0.06% | -28.4% |
| Q3 2021 | $4,967,000 | +247.1% | 150,703 | +565.7% | 0.08% | +200.0% |
| Q2 2021 | $1,431,000 | -15.0% | 22,638 | -23.1% | 0.03% | -43.8% |
| Q4 2020 | $1,684,000 | +179.7% | 29,448 | +47.7% | 0.05% | +84.6% |
| Q3 2020 | $602,000 | – | 19,941 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |